IBDEI14Y ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18968,1,3,0)
 ;;=3^Malig Neop Left Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,18968,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,18968,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,18969,0)
 ;;=C78.02^^94^916^131
 ;;^UTILITY(U,$J,358.3,18969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18969,1,3,0)
 ;;=3^Malig Neop Left Lung,Secondary
 ;;^UTILITY(U,$J,358.3,18969,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,18969,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,18970,0)
 ;;=C78.7^^94^916^136
 ;;^UTILITY(U,$J,358.3,18970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18970,1,3,0)
 ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
 ;;^UTILITY(U,$J,358.3,18970,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,18970,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,18971,0)
 ;;=C79.71^^94^916^149
 ;;^UTILITY(U,$J,358.3,18971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18971,1,3,0)
 ;;=3^Malig Neop Right Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,18971,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,18971,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,18972,0)
 ;;=C78.01^^94^916^153
 ;;^UTILITY(U,$J,358.3,18972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18972,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,18972,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,18972,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,18973,0)
 ;;=C79.70^^94^916^104
 ;;^UTILITY(U,$J,358.3,18973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18973,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,18973,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,18973,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,18974,0)
 ;;=C78.00^^94^916^137
 ;;^UTILITY(U,$J,358.3,18974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18974,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,18974,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,18974,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,18975,0)
 ;;=D57.1^^94^916^178
 ;;^UTILITY(U,$J,358.3,18975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18975,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,18975,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,18975,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,18976,0)
 ;;=D75.1^^94^916^176
 ;;^UTILITY(U,$J,358.3,18976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18976,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,18976,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,18976,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,18977,0)
 ;;=C90.30^^94^916^179
 ;;^UTILITY(U,$J,358.3,18977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18977,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,18977,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,18977,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,18978,0)
 ;;=D56.3^^94^916^180
 ;;^UTILITY(U,$J,358.3,18978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18978,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,18978,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,18978,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,18979,0)
 ;;=D56.9^^94^916^181
 ;;^UTILITY(U,$J,358.3,18979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18979,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,18979,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,18979,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,18980,0)
 ;;=M31.1^^94^916^183
 ;;^UTILITY(U,$J,358.3,18980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18980,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,18980,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,18980,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,18981,0)
 ;;=D51.2^^94^916^184
